CCNG1 Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P51959 |
---|---|
Clone Names | 80102163 |
Gene ID | 900 |
---|---|
Other Names | Cyclin-G1, Cyclin-G, CCNG1, CCNG, CYCG1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | CCNG1 |
---|---|
Synonyms | CCNG, CYCG1 |
Function | May play a role in growth regulation. Is associated with G2/M phase arrest in response to DNA damage. May be an intermediate by which p53 mediates its role as an inhibitor of cellular proliferation (By similarity). |
Cellular Location | Nucleus. Note=DNA replication foci after DNA damage |
Tissue Location | High levels in skeletal muscle, ovary, kidney and colon |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The eukaryotic cell cycle is governed by cyclin-dependentprotein kinases (CDKs) whose activities are regulated by cyclinsand CDK inhibitors. The protein encoded by this gene is a member ofthe cyclin family and contains the cyclin box. The encoded proteinlacks the protein destabilizing (PEST) sequence that is present inother family members. Transcriptional activation of this gene canbe induced by tumor protein p53. Two transcript variants encodingthe same protein have been identified for this gene. [provided byRefSeq].
References
Cunningham, J.M., et al. Br. J. Cancer 101(8):1461-1468(2009)Fornari, F., et al. Cancer Res. 69(14):5761-5767(2009)Li, H., et al. Mol. Cell. Biol. 29(3):919-928(2009)Piscopo, D.M., et al. Cancer Res. 68(14):5581-5590(2008)Seo, H.R., et al. J. Biol. Chem. 283(23):15601-15610(2008)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.